LA

Lakshmamma Anjaneya

Active Director Director DIN 08869584
DIN 08869584 First appointment Sep 2020 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Lakshmamma Anjaneya

Data last updated:

Lakshmamma Anjaneya is a Director at Kiran Nuclear Medicine And Pet Ct Private Limited (since 2020). The company operates in Non-Profit Organizations.

DIN 08869584
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 08 Sep 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Sep 20202020Active

Board colleagues of Lakshmamma Anjaneya

NameDINCompanyDesignation
Kiran Kumar08869583Kiran Nuclear Medicine And Pet Ct Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kiran Nuclear Medicine And Pet Ct Private Limited
Premium access

Shareholding and investment profile for Lakshmamma Anjaneya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakshmamma Anjaneya

Lakshmamma Anjaneya currently holds 1 directorship: Kiran Nuclear Medicine And Pet Ct Private Limited (Director, since 08 Sep 2020).

Lakshmamma Anjaneya was first appointed on 08 Sep 2020 as Director at Kiran Nuclear Medicine And Pet Ct Private Limited.

The current boards of Lakshmamma Anjaneya's companies include Kiran Kumar (Kiran Nuclear Medicine And Pet Ct Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available